Literature DB >> 12416679

Molecular characterization of a full genome Turkish hepatitis C virus 1b isolate (HCV-TR1): a predominant viral form in Turkey.

Esra Yildiz1, Asli Oztan, Funda Sar, Ergun Pinarbasi, Rengul Cetin-Atalay, Hikmet Akkiz, Mehmet Ozturk.   

Abstract

Based on direct sequencing information from 5'UTR and NS5B regions, we identified subtype lb as a predominant hepatitis C virus genome in Turkey, which affected more than 91% of 79 patients studied. Next, the full genome sequence of a Turkish lb isolate was obtained by the cloning of polypeptide-encoding region into 7 overlapping fragments. Turkish 1b isolate, which was named HCV-TR1, comprises 9361 nucleotides, including 306 nucleotides of 5'UTR, a single long open reading frame of 9033 nucleotides, and 22 nucleotides of 3'UTR. When compared to HCV lb polypeptide sequences available at GenBank, the predicted polypeptide displayed a total of 36 amino acid substitutions, of which 16 was specific for HCV-TR1 isolate. Despite these changes, major structural and functional motifs of HCV proteins were maintained in HCV-TR1. In contrast, HCV-TR1 displayed amino acid substitutions in 6 out of 9 major cytotoxic T-cell epitopes. These data suggest that HCV-TR1 encodes functionally intact viral proteins, but it also encodes altered viral epitopes, which may affect host immune-response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12416679     DOI: 10.1023/a:1020161818764

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  28 in total

1.  Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

Authors:  E Silini; R Bottelli; M Asti; S Bruno; M E Candusso; S Brambilla; F Bono; G Iamoni; C Tinelli; M U Mondelli; G Ideo
Journal:  Gastroenterology       Date:  1996-07       Impact factor: 22.682

2.  Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide.

Authors:  J L Kim; K A Morgenstern; C Lin; T Fox; M D Dwyer; J A Landro; S P Chambers; W Markland; C A Lepre; E T O'Malley; S L Harbeson; C M Rice; M A Murcko; P R Caron; J A Thomson
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

3.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; T Sugimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis.

Authors:  L Benvegnù; P Pontisso; D Cavalletto; F Noventa; L Chemello; A Alberti
Journal:  Hepatology       Date:  1997-01       Impact factor: 17.425

5.  Glycosylation of the hepatitis C virus envelope protein E1 is dependent on the presence of a downstream sequence on the viral polyprotein.

Authors:  J Dubuisson; S Duvet; J C Meunier; A Op De Beeck; R Cacan; C Wychowski; L Cocquerel
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

6.  Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action.

Authors:  C Bréchot; F Jaffredo; D Lagorce; G Gerken; K Meyer zum Büschenfelde; A Papakonstontinou; S Hadziyannis; R Romeo; M Colombo; J Rodes; J Bruix; R Williams; N Naoumov
Journal:  J Hepatol       Date:  1998-08       Impact factor: 25.083

7.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Hepatitis C virus infection and genotypes in Southern Israel and the Gaza Strip.

Authors:  Y Shemer-Avni; Z el Astal; O Kemper; K J el Najjar; A Yaari; N Hanuka; M Margalith; E Sikuler
Journal:  J Med Virol       Date:  1998-11       Impact factor: 2.327

9.  Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.

Authors:  N Enomoto; I Sakuma; Y Asahina; M Kurosaki; T Murakami; C Yamamoto; Y Ogura; N Izumi; F Marumo; C Sato
Journal:  N Engl J Med       Date:  1996-01-11       Impact factor: 91.245

Review 10.  Variability of hepatitis C virus.

Authors:  P Simmonds
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

View more
  4 in total

1.  Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey.

Authors:  Emekdas Gurol; Cavuslu Saban; Oncul Oral; Artuk Cigdem; Aksoy Armagan
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

2.  Prolidase and oxidative stress in chronic hepatitis C.

Authors:  Fazilet Duygu; Suda Tekin Koruk; Hasan Karsen; Nurten Aksoy; Abdullah Taskin; Melek Hamidanoglu
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

3.  The "hidden" epidemic: a snapshot of Moroccan intravenous drug users.

Authors:  Roxana-Delia Trimbitas; Fatima Zahra Serghini; Fatiha Lazaar; Warda Baha; Abderrahim Foullous; Mohammed Essalhi; Abdelouahed El Malki; Abdelkrim Meziane Bellefquih; Abdelouaheb Bennani
Journal:  Virol J       Date:  2014-03-06       Impact factor: 4.099

4.  The Prevalence of Hepatitis B and C Among Prisoners in Kahramanmaras, Turkey.

Authors:  Derya Keten; Mehmet Emin Ova; Hamit Sirri Keten; Alper Keten; Evrim Gulderen; Seray Tumer; Ahmet Caliskan; Suleyman Kulotu
Journal:  Jundishapur J Microbiol       Date:  2016-02-13       Impact factor: 0.747

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.